In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Unable to Get Prized Cow, Guidant Buys Cook's Farm--Maybe

Executive Summary

After apparently exhausting every other means of obtaining access to the drug it needs to enter the drug-eluting stent market as quickly as possible, Guidant's decision to acquire Cook Group for $3 billion hinges on whether a Federal judge agrees with Guidant's argument that the deal doesn't result in an ownership change of the Cook Group's Cook Inc. subsidiary.

Related Content

Biosensors: Small Company Turns Major Dealmaker
Conor: An Outsider Delivers Drug-Stents' Next Generation
If Behind, Look Two-Steps Ahead: Guidant Launches Bioabsorbable Stent Group
Medical Acquisitions: No Icebreaker in Sight
Medical Acquisitions: No Icebreaker in Sight
Deal Statistics Quarterly, Q3 2002
Deal Statistics Quarterly, Q3 2002
Hijacking the Restenosis Market


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts